Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.
about
Population genetics of malaria resistance in humansRelating mutant genotype to phenotype via quantitative behavior of the NADPH redox cycle in human erythrocytesG6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based mapGlucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort StudyThe challenges of introducing routine G6PD testing into radical cure: a workshop report.Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individualsGlucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, MaliAssociation of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania.Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency.Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali.Genetic determinants of glucose-6-phosphate dehydrogenase activity in KenyaGlucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trialsRisks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in InfantsGlucose-6-phosphate dehydrogenase deficiency among malaria patients of Honduras: a descriptive study of archival blood samples.PharmGKB summary: very important pharmacogene information for G6PD.Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malaria.Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda.Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency.Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.PCR-based allelic discrimination for glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ugandan umbilical cord blood.The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school childrenScreening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.High resolution melting curve analysis enables rapid and reliable detection of G6PD variants in heterozygous females
P2860
Q21032506-DCC73CAE-EE37-4D1A-9C94-97582CF472BAQ28475622-95460C21-62D3-49B1-AA8E-95DBA4296131Q28485156-B1F673D8-C322-486B-B968-6C58AA31E21BQ28547654-0B4DA426-AAEF-4E98-BC44-434D2E3D4F9FQ30666192-8182C90C-A5A8-4611-99D4-F1AAB05CF616Q31075666-093A42E2-548D-41D3-A27E-92B1FEE85497Q33826283-C6CC6A93-4958-4544-AA8C-09D4E957935FQ33948158-39E7D137-FF4D-42AA-B5C4-0E5F80FEFE9BQ34005594-9C3B93E7-C9B1-4ED7-B98D-A72B57D50B8DQ34131141-06595027-2FAD-4CC0-BC59-8E597C6751E2Q34281695-06512AF5-BC57-47C7-A7BE-0302497357A9Q34398049-62714146-2D8C-42EE-9F86-F10C9A1C563EQ34538235-D307C18E-15E3-45F1-A9C3-05EDE32154E4Q34611917-BA8C137A-000D-4D9E-B6CA-9C536484A0C6Q35283214-11DCB50D-8106-42F4-BA94-8D89CBFCB3ADQ35850290-22685142-E6E0-4A3E-A88F-1DBC0AC09135Q35927594-1CFF342E-3F96-4B55-A8CD-515D41FB7220Q36055205-1585C7FB-8B9C-4E83-95F4-E0715511704BQ36439614-62C546DF-55CB-41AD-A3A9-C77BC92FB058Q36952371-E7D07E16-BBB3-47F7-AA9A-704925CF1076Q37152432-8C070583-5F80-4C8C-BDD8-59DDE2A3D39EQ37574319-9B29A053-1670-4007-BA3D-57CAB7FC0C9EQ37581776-C5E2708F-8BCE-48C5-8819-CD4EE39DCE00Q37723447-26F44E97-FA95-4A87-A70C-90C80958C22CQ38852349-DEB522BB-12D4-4C34-B4EF-AF0BFFFD2CAAQ43721671-A3DE189C-711C-484C-948D-415C617802D6Q52348869-06AC23FF-EE60-4A8F-B9C0-5D9B0C10315CQ57928268-AB227675-C4C9-4564-B30F-29CA6B772796
P2860
Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Impact of the method of G6PD d ...... ies of malaria susceptibility.
@ast
Impact of the method of G6PD d ...... ies of malaria susceptibility.
@en
type
label
Impact of the method of G6PD d ...... ies of malaria susceptibility.
@ast
Impact of the method of G6PD d ...... ies of malaria susceptibility.
@en
prefLabel
Impact of the method of G6PD d ...... ies of malaria susceptibility.
@ast
Impact of the method of G6PD d ...... ies of malaria susceptibility.
@en
P2093
P2860
P1433
P1476
Impact of the method of G6PD d ...... ies of malaria susceptibility.
@en
P2093
Marla K Johnson
Sunil Parikh
Tamara D Clark
P2860
P356
10.1371/JOURNAL.PONE.0007246
P407
P577
2009-09-30T00:00:00Z